The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

Researchers say semaglutide may help reverse MASH, a progressive liver condition affecting millions of Americans.

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic dysfunction-associated steatohepatitis and moderate or advanced liver ...

The New England Journal of Medicine (NEJM) published results from part 1 of the ongoing phase 3 ESSENCE trial which investigated the effects of once-weekly subcutaneous semaglutide 2.4 mg on liver ...

Mar. 24, 2025 — A comprehensive study shows that people with fatty liver disease have almost twice the mortality rate of the general population. They have an increased risk of dying from both ...

A research team has developed an innovative biomimetic dual-mode magnetic resonance imaging (MRI) nanoprobe for detecting ...

Parenteral nutrition (PN) is lifesaving for patients with short bowel syndrome and other gastrointestinal disorders, however long-term use may lead to complications including hepatosteatosis and ...

Cirrhosis of the liver is a severe condition, causing scarring and permanent damage to the liver. Life expectancy depends on the stage and type of liver cirrhosis, but it may vary between roughly ...

In February, sources told ABC News that Trachtenberg “recently underwent a liver transplant and may have been experiencing complications.” A year before her death, Trachtenberg addressed and ...